» Articles » PMID: 26233430

Eosinophilic Esophagitis and Gastroenteritis

Overview
Date 2015 Aug 3
PMID 26233430
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Eosinophilic gastrointestinal disease (EGID) can be classified as eosinophilic esophagitis (EoE) when the eosinophilia is limited to the esophagus or as eosinophilic gastritis (EG) if it is limited to the gastric tract, eosinophilic colitis (EC) if it is limited to the colon, and eosinophilic gastroenteritis (EGE) if the eosinophilia involves one or more parts of the gastrointestinal tract. EoE is by far the most common EGID. It is a well-defined chronic atopic disease due to a T helper type 2 (Th2) inflammation triggered often by food allergens. EoE diagnosis is done if an esophageal biopsy shows at least 15 eosinophils per high power field (eos/hpf). Globally accepted long-term therapies for EoE are the use of swallowed inhaled steroids or food antigen avoidance. The treatment of EoE is done not only to control symptoms but also to prevent complications such as esophageal stricture and food impaction. EGE cause non-specific gastrointestinal (GI) symptoms and are diagnosed if esophagogastroduodenoscopy (EGD)/colonoscopy show eosinophilia in one or more parts of the GI tract. They are rare diseases with an unclear pathogenesis, and they are poorly defined in terms of diagnostic criteria and treatment. Before initiating treatment of any EGE, it is imperative to conduct a differential diagnosis to exclude other causes of hypereosinophilia with GI localization. EGE are often poorly responsive to therapy and there is no commonly accepted long-term treatment. EG has many characteristics similar to EoE, including the fact that it is often due to a food allergen-driven Th2 inflammation; transcriptome analysis however shows that it is more a systemic disease and has a different gene signature than EoE. EC is a benign form of delayed food allergy in infant and is instead a difficult-to-treat severe inflammatory condition in older children and adults. EC in the latter groups can be a manifestation of drug allergy or autoimmune disease. Overall EGE, EC, and EG are rare and are a diagnosis of exclusion until more common causes of eosinophilia have been excluded.

Citing Articles

A Patient With Eosinophilic Gastroenteritis Presenting With Severe Abdominal Pain.

Islam S, Ahmed D, Khan N, Rakhi F Clin Case Rep. 2024; 12(12):e9667.

PMID: 39649514 PMC: 11622149. DOI: 10.1002/ccr3.9667.


An efficient computational framework for gastrointestinal disorder prediction using attention-based transfer learning.

Zhou J, Song W, Liu Y, Yuan X PeerJ Comput Sci. 2024; 10:e2059.

PMID: 38855223 PMC: 11157572. DOI: 10.7717/peerj-cs.2059.


Clinical and atopic features of patients with primary eosinophilic colitis: an Italian multicentre study.

Rossi C, Lenti M, Merli S, Lo Bello A, Mauro A, Anderloni A Intern Emerg Med. 2024; 19(4):993-1005.

PMID: 38461469 PMC: 11186925. DOI: 10.1007/s11739-024-03568-w.


Identification of CXC Chemokine Receptor 2 (CXCR2) as a Novel Eosinophils-Independent Diagnostic Biomarker of Pediatric Eosinophilic Esophagitis by Integrated Bioinformatic and Machine-Learning Analysis.

Wu J, Duan C, Han C, Hou X Immunotargets Ther. 2024; 13:55-74.

PMID: 38328342 PMC: 10849108. DOI: 10.2147/ITT.S439289.


Descriptive Analysis of Pre-existing Data on Eosinophilic Esophagitis and Associated Morbidities in Cleveland Clinic Abu Dhabi, United Arab Emirates.

Abuzakouk M, Yousef O, Fahmy M, Chouikrat Z Cureus. 2024; 16(1):e51493.

PMID: 38304666 PMC: 10831211. DOI: 10.7759/cureus.51493.


References
1.
Kristopaitis T, Neghme C, Yong S, Chejfec G, Aranha G, Keshavarzian A . Giant antral ulcer: a rare presentation of eosinophilic gastroenteritis--case report and review of the literature. Am J Gastroenterol. 1997; 92(7):1205-8. View

2.
Blanchard C, Stucke E, Burwinkel K, Caldwell J, Collins M, Ahrens A . Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol. 2010; 184(7):4033-41. PMC: 3807813. DOI: 10.4049/jimmunol.0903069. View

3.
Lucendo A, Arias A, Tenias J . Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2014; 113(6):624-9. DOI: 10.1016/j.anai.2014.08.004. View

4.
Rothenberg M, Aceves S, Bonis P, Collins M, Gonsalves N, Gupta S . Working with the US Food and Drug Administration: progress and timelines in understanding and treating patients with eosinophilic esophagitis. J Allergy Clin Immunol. 2012; 130(3):617-9. PMC: 3828675. DOI: 10.1016/j.jaci.2012.06.051. View

5.
Hogan S, Mishra A, Brandt E, Royalty M, Pope S, Zimmermann N . A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nat Immunol. 2001; 2(4):353-60. DOI: 10.1038/86365. View